2008-05-26 18:16:35 -
CDISC Japan Interchange - XClinical GmbH Olga Steinle, +49 (0)89 / 45 22 77 - 52 10, press@xclinical.com XClinical, a European vendor of innovative software products for eClinical trials, and known for its innovative and user-friendly CDISC ODM certified EDC software suite MARVIN, today announced its comprehensive participation at the CDISC Interchange in Tokyo, Japan.
The exhibition
will take place jointly with Asklep, the company's Japanese customer: "ASKLEP is the first Japanese CRO to join CDISC and having a CDISC ODM Certified partner like XClinical certainly speeds up our goal for having a global standard EDC solution for our clients here in Japan" said Toshio Yoshii, Ph.D., and Director of Clinical Information Division at ASKLEP.
XClinical executives will be involved in both CDISC presentations and training sessions. Dr. Claus Lindenau, XClinical's head of business development, will present a lecture entitled "End To End Processing - A presentation of CDISC certified tools and their benefits in clinical research". The presentation will emphasize how the process from study design via data capture to submission and archival can profit from using a combination of CDISC based software solutions.
Dr. Philippe Verplancke, XClinical's CEO, will lead the ODM training course on Tuesday, June 3. The training provides an in-depth understanding of the CDISC standards ODM and define.xml and how the underlying XML technology can support the complete clinical data management process from CRF design to submission.
About XClinical
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM). Till today, MARVIN was used to collect and process data of more than 50,000 patients in 50+ studies.
About Asklep
Asklep, Inc., (www.asklep.co.jp) founded in 1992, in Tokyo, Japan, provides clinical research services in monitoring, data management, biostatistics, regulatory & consulting, CRA training, etc. ASKLEP is an INTAGE Group Company. INTAGE, INC., (www.intage.co.jp) is the largest marketing research company in Japan and the eleventh largest globally. It has one of the most comprehensive healthcare solution services in the industry
¶ At the CDISC Japan Interchange to be held in Tokyo on June 3-6,
2008, XClinical jointly exhibits with its Japanese CRO partner Asklep.
XClinical has been selected for an ODM training course and for a
presentation in the area "Vendor Applications and Tools".
